These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 32895782)
21. Back to the Future: Lipiodol in Lymphography-From Diagnostics to Theranostics. Pieper CC; Hur S; Sommer CM; Nadolski G; Maleux G; Kim J; Itkin M Invest Radiol; 2019 Sep; 54(9):600-615. PubMed ID: 31283538 [TBL] [Abstract][Full Text] [Related]
22. Pressure-Enabled Drug Delivery Approach in the Pancreas with Retrograde Venous Infusion of Lipiodol with Ex Vivo Analysis. Arepally A; Chomas J; Katz SC; Jaroch D; Kolli KP; Prince E; Liddell RP Cardiovasc Intervent Radiol; 2021 Jan; 44(1):141-149. PubMed ID: 32895782 [TBL] [Abstract][Full Text] [Related]
23. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Idée JM; Guiu B Crit Rev Oncol Hematol; 2013 Dec; 88(3):530-49. PubMed ID: 23921081 [TBL] [Abstract][Full Text] [Related]
24. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. de Baere T; Arai Y; Lencioni R; Geschwind JF; Rilling W; Salem R; Matsui O; Soulen MC Cardiovasc Intervent Radiol; 2016 Mar; 39(3):334-43. PubMed ID: 26390875 [TBL] [Abstract][Full Text] [Related]
25. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. Maeda H J Control Release; 2012 Dec; 164(2):138-44. PubMed ID: 22595146 [TBL] [Abstract][Full Text] [Related]
26. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. Lencioni R; de Baere T; Soulen MC; Rilling WS; Geschwind JF Hepatology; 2016 Jul; 64(1):106-16. PubMed ID: 26765068 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]